Global Cord Blood Profit Margin

Global Cord Blood (CO) currently reports a profit margin of 38.59% as of July 2022. That compares with 42.9% in the prior-year period — down 10.0% year over year. That is above the Healthcare sector average of 13.89%. Use the charts on this page to explore Global Cord Blood's profit margin history and peer comparisons.

Global Cord Blood's profit margin decreased from 42.9% to 38.59% — a 10.0% year-over-year decrease (period ending July 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Global Cord Blood's profit margin of 38.59% is higher than the Healthcare sector average of 13.89%. That is roughly 177.7% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Global Cord Blood's current 38.59% should be judged against Healthcare norms (sector average: 13.89%) and against CO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 38.59%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Global Cord Blood, and consider following CO for alerts when major investors trade the stock.